HKEX: 455
Interim Report 2026
Earlier from Tianda Pharmaceuticals
- Tianda Pharma Announces 2022/23 Interim Results
- Tianda Pharmaceuticals Annual Results 2022
- Tianda Pharmaceuticals: Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout
- Tianda Pharmaceuticals: acquires Yeung & Young Medicare and Qi's Living, establishing long-term cooperation
